These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9815900

  • 1. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
    Sinicrope FA, Hart J, Michelassi F, Lee JJ.
    Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
    [Abstract] [Full Text] [Related]

  • 2. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC.
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [Abstract] [Full Text] [Related]

  • 3. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, Monges G.
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U.
    Cancer; 1996 Jan 15; 77(2):255-64. PubMed ID: 8625232
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE, North Central Cancer Treatment Group.
    J Clin Oncol; 2004 May 01; 22(9):1572-82. PubMed ID: 15117979
    [Abstract] [Full Text] [Related]

  • 6. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 01; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 7. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 Nov 01; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS, Waelchli L, Bründler MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L.
    Laryngoscope; 2000 Aug 15; 110(8):1339-45. PubMed ID: 10942137
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
    Jäckel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W.
    Cancer; 1999 Feb 01; 85(3):591-9. PubMed ID: 10091732
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Feb 01; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 12. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Fernö M, Parwaresch R, Alm P.
    J Pathol; 1999 Jan 01; 187(2):207-16. PubMed ID: 10365096
    [Abstract] [Full Text] [Related]

  • 13. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
    Zhang GJ, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K, Tsuchiya A.
    Anticancer Res; 1998 Jan 01; 18(3B):1989-98. PubMed ID: 9677455
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Jan 01; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A, Alivizatos G, Bamias A, Mitropoulos D, Ferakis N, Deliveliotis C, Dimopoulos MA.
    Int J Urol; 2005 Jun 01; 12(6):563-9. PubMed ID: 15985079
    [Abstract] [Full Text] [Related]

  • 16. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C.
    Cytometry; 2002 Aug 15; 50(4):203-9. PubMed ID: 12210599
    [Abstract] [Full Text] [Related]

  • 17. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 15; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 15; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Yamamoto E.
    J Oral Pathol Med; 2008 Jul 12; 37(6):364-71. PubMed ID: 18410312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.